Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT06871410 · RECRUITING
Trial details
- NCT number
- NCT06871410
- Sponsor
- Roswell Park Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2028-04-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.